The role of FoxO in the regulation of metabolism

Forkhead proteins, and FoxO1 in particular, play a significant role in regulating whole body energy metabolism. Glucose homeostasis is achieved by adjusting endogenous glucose production as well as glucose uptake by peripheral tissues in response to insulin. In the fasted state, the liver is primarily responsible for maintaining glucose levels, with FoxO1 playing a key role in promoting the expression of gluconeogenic enzymes. Following feeding, pancreatic beta cells secrete insulin, which promotes the uptake of glucose by peripheral tissues including skeletal muscle and adipose tissue, and can in part suppress gluconeogenic enzyme expression in the liver. In addition to directly regulating metabolism, FoxO1 also plays a role in the formation of both adipose tissue and skeletal muscle, two major organs that are critical for maintaining energy homeostasis. The importance of FoxO1 in energy homeostasis is particularly striking under conditions of metabolic dysfunction or insulin resistance. In obese or diabetic states, FoxO1-dependent gene expression promotes some of the deleterious characteristics associated with these conditions, including hyperglycemia and glucose intolerance. In addition, the increase in pancreatic beta cell mass that normally occurs in response to a rise in insulin demand is blunted by nuclear FoxO1 expression. However, under these same pathophysiological conditions, FoxO1 expression may help drive the expression of genes involved in combating oxidative stress, thereby preserving cellular function. FoxO1 may also be involved in promoting the switch from carbohydrate to fatty acid as the major energy source during starvation.

[1]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[2]  K. Kaestner,et al.  Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. , 2002, Diabetes.

[3]  L. Guarente,et al.  Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans , 2001, Nature.

[4]  V. Grill,et al.  Overstimulation and beta-cell function. , 2001, Diabetes.

[5]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.

[6]  R. Nusse,et al.  Wnt signaling regulates pancreatic β cell proliferation , 2007, Proceedings of the National Academy of Sciences.

[7]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[8]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[9]  M. Primig,et al.  Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. , 2000, Molecular biology of the cell.

[10]  M. Prentki,et al.  Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells , 1999, Diabetologia.

[11]  R. Mattingly,et al.  High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis , 2002, The Journal of cell biology.

[12]  S. G. Rønn,et al.  Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. , 2005, Journal of molecular endocrinology.

[13]  H. Kaneto,et al.  Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. , 2007, Current medicinal chemistry.

[14]  H. Kiyonari,et al.  Forkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure , 2008, Diabetes.

[15]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[16]  J. Habener,et al.  Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation* , 2008, Journal of Biological Chemistry.

[17]  Jie Chen,et al.  The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism* , 2001, The Journal of Biological Chemistry.

[18]  A. Russell,et al.  Akt signalling through GSK‐3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy , 2006, The Journal of physiology.

[19]  L. Sussel,et al.  Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  D. Allen,et al.  Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors , 2007 .

[22]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[23]  M. Stoffel,et al.  beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. , 2002, Nature genetics.

[24]  T. Hunter,et al.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Munday,et al.  Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. , 1998, Diabetes.

[26]  Sunmin Park,et al.  Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. , 2006, The Journal of biological chemistry.

[27]  J. Altomonte,et al.  PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. , 2007, American journal of physiology. Endocrinology and metabolism.

[28]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Wilson,et al.  Selective Control of Skeletal Muscle Differentiation by Akt1* , 2007, Journal of Biological Chemistry.

[30]  M. LaDu,et al.  Regulation of lipoprotein lipase in adipose and muscle tissues during fasting. , 1991, The American journal of physiology.

[31]  R. Morrison,et al.  Hormonal signaling and transcriptional control of adipocyte differentiation. , 2000, The Journal of nutrition.

[32]  R A Roth,et al.  Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. , 2001, Biochemical and biophysical research communications.

[33]  A. Lombardi,et al.  Fuel economy in food‐deprived skeletal muscle: signaling pathways and regulatory mechanisms , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Miki Suzuki,et al.  A forkhead transcription factor FKHR up‐regulates lipoprotein lipase expression in skeletal muscle , 2003, FEBS letters.

[35]  K. Kaestner,et al.  Winged-helix transcription factors and pancreatic development. , 2005, Clinical science.

[36]  J. Girard,et al.  Role of the liver in the control of carbohydrate and lipid homeostasis. , 2004, Diabetes & metabolism.

[37]  D. Accili,et al.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. , 2006, The Journal of clinical investigation.

[38]  M. Boylan,et al.  Glucose-Dependent Insulinotropic Polypeptide (GIP) , 1999 .

[39]  R. Ajisaka,et al.  The regulation of adiponectin receptors expression by acute exercise in mice. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[40]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[41]  G. Shulman,et al.  Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action , 2006, Diabetes.

[42]  A. Russell,et al.  Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  P. J. Randle Fuel selection in animals. , 1986, Biochemical Society transactions.

[44]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[45]  E. Cerasi,et al.  A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), HNF-1alpha, and SPs transcription factors. , 2001, The Journal of biological chemistry.

[46]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[47]  O. MacDougald,et al.  Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.

[48]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[49]  W. Mitch,et al.  Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. , 2004, Journal of the American Society of Nephrology : JASN.

[50]  K. Esser,et al.  FoxO1 Stimulates Fatty Acid Uptake and Oxidation in Muscle Cells through CD36-dependent and -independent Mechanisms* , 2005, Journal of Biological Chemistry.

[51]  R. DePinho,et al.  A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. , 2007, The Journal of clinical investigation.

[52]  A. Fukamizu,et al.  The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. , 2006, The Journal of clinical investigation.

[53]  T. Jin The WNT signalling pathway and diabetes mellitus , 2008, Diabetologia.

[54]  Peter Tontonoz,et al.  Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors* , 2002, The Journal of Biological Chemistry.

[55]  N. Motoyama,et al.  FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. , 2005, Antioxidants & redox signaling.

[56]  C. Kahn,et al.  SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. , 2007, Cell metabolism.

[57]  R. Stein,et al.  Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene , 1997, Molecular and cellular biology.

[58]  M. McVey,et al.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. , 1999, Genes & development.

[59]  Hui Chen,et al.  FOXO1 Represses Peroxisome Proliferator-activated Receptor-γ1 and -γ2 Gene Promoters in Primary Adipocytes , 2006, Journal of Biological Chemistry.

[60]  土田 敦之 Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity , 2005 .

[61]  G. Sharp,et al.  Glucose‐stimulated signaling pathways in biphasic insulin secretion , 2002, Diabetes/metabolism research and reviews.

[62]  Jinfei Xu,et al.  Protein Kinase B/AKT 1 Plays a Pivotal Role in Insulin-like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.

[63]  W. Mitch,et al.  Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.

[64]  A. Hevener,et al.  PPARdelta regulates glucose metabolism and insulin sensitivity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  F. Booth,et al.  Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells. , 2008, American journal of physiology. Cell physiology.

[66]  S. Farmer Regulation of PPARgamma activity during adipogenesis. , 2005, International journal of obesity.

[67]  V. Large,et al.  Metabolism of lipids in human white adipocyte. , 2004, Diabetes & metabolism.

[68]  M. Palacín,et al.  Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. , 1998, Molecular endocrinology.

[69]  V. Grill,et al.  Short-term intermittent exposure to diazoxide improves functional performance of beta-cells in a high-glucose environment. , 2004, American journal of physiology. Endocrinology and metabolism.

[70]  K. Guan,et al.  Negative Regulation of the Forkhead Transcription Factor FKHR by Akt* , 1999, The Journal of Biological Chemistry.

[71]  B. Spiegelman,et al.  Molecular regulation of adipogenesis. , 2000, Annual review of cell and developmental biology.

[72]  B. Hemmings,et al.  PKBα is required for adipose differentiation of mouse embryonic fibroblasts , 2006, Journal of Cell Science.

[73]  M. Matsuda,et al.  Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.

[74]  Ying-Chu Lee,et al.  STAT5 Activity in Pancreatic β-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes , 2006, Diabetes.

[75]  P. Vogt,et al.  An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[76]  O. Chepurny,et al.  Diabetes Outfoxed by GLP-1? , 2005, Science's STKE.

[77]  R. Tjian,et al.  Codependent activators direct myoblast-specific MyoD transcription. , 2008, Developmental cell.

[78]  M. Lane,et al.  Mitotic clonal expansion: A synchronous process required for adipogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Kushner,et al.  Pdx1 restores β cell function in Irs2 knockout mice , 2002 .

[80]  R. O’Brien,et al.  Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.

[81]  A. Brunet,et al.  FoxO transcription factors in the maintenance of cellular homeostasis during aging. , 2008, Current opinion in cell biology.

[82]  T. Noda,et al.  Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. , 2008, Cell metabolism.

[83]  T. Fielder,et al.  Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. , 2003, American journal of physiology. Endocrinology and metabolism.

[84]  B. Spiegelman,et al.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.

[85]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[86]  Jerrold M. Olefsky,et al.  PPARδ regulates glucose metabolism and insulin sensitivity , 2006 .

[87]  M. Febbraio,et al.  FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle* , 2007, Journal of Biological Chemistry.

[88]  L. N. Valenti,et al.  Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes* , 2005, Journal of Biological Chemistry.

[89]  A. Goldberg,et al.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[90]  Xueying Lin,et al.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. , 2006, The Journal of clinical investigation.

[91]  D. Glass Signalling pathways that mediate skeletal muscle hypertrophy and atrophy , 2003, Nature Cell Biology.

[92]  P. Cohen,et al.  Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.

[93]  R. Evans,et al.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. , 2003, Cell.

[94]  J. Altomonte,et al.  Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. , 2006, Endocrinology.

[95]  C. Mcintosh,et al.  Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression* , 2005, Journal of Biological Chemistry.

[96]  D. Accili,et al.  Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic β-Cell Mass , 2006, Diabetes.

[97]  B. Burgering,et al.  Cell cycle and death control: long live Forkheads. , 2002, Trends in biochemical sciences.

[98]  J. Egan,et al.  Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. , 1999, Endocrinology.

[99]  J. Auwerx,et al.  E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.

[100]  Jourdan J. Pouliot,et al.  development and , 2019 .

[101]  S. Mandrup,et al.  Regulating Adipogenesis* , 1997, The Journal of Biological Chemistry.

[102]  Satoko Aratani,et al.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[103]  P. Puigserver,et al.  Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[104]  M. Meseck,et al.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. , 2008, The Journal of clinical investigation.

[105]  Philippe Lefebvre,et al.  Sorting out the roles of PPARα in energy metabolism and vascular homeostasis , 2006 .

[106]  M. Stoffel,et al.  Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[107]  R. Silverstein,et al.  Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* , 2000, The Journal of Biological Chemistry.

[108]  J. Altomonte,et al.  PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .

[109]  R. Robertson,et al.  Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. , 2002, Endocrinology.

[110]  T. Kitamura,et al.  Role of FoxO Proteins in Pancreatic β Cells , 2007 .

[111]  W. Pang,et al.  Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes , 2007, Molecular and Cellular Biochemistry.

[112]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[113]  Q. Tong,et al.  SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. , 2008, Molecular biology of the cell.

[114]  A. F. Stewart,et al.  Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia* , 2000, The Journal of Biological Chemistry.

[115]  M. Lane,et al.  Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. , 2003, The Journal of biological chemistry.

[116]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[117]  A. Fukamizu,et al.  Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development , 2007, The EMBO journal.

[118]  S. Bonner-Weir,et al.  Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.

[119]  R. Robertson,et al.  Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. , 2004, Diabetes.

[120]  P. Puigserver,et al.  O-GlcNAc Regulates FoxO Activation in Response to Glucose* , 2008, Journal of Biological Chemistry.

[121]  A. Fukamizu,et al.  Hepatocyte Nuclear Factor-4 Is a Novel Downstream Target of Insulin via FKHR as a Signal-regulated Transcriptional Inhibitor* , 2003, The Journal of Biological Chemistry.

[122]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[123]  P. Puigserver,et al.  Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  C. Burant,et al.  Role of FoxO1 in FFA-induced oxidative stress in adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[125]  P. Rotwein,et al.  Insulin-like Growth Factor-mediated Muscle Differentiation , 2001, The Journal of Biological Chemistry.

[126]  I. Rooman,et al.  Regulation of pancreatic beta-cell mass. , 2005, Physiological reviews.

[127]  S. Bodine,et al.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.

[128]  J. Gustafsson,et al.  Liver X Receptors as Insulin-mediating Factors in Fatty Acid and Cholesterol Biosynthesis* , 2002, The Journal of Biological Chemistry.

[129]  D. Accili,et al.  Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[130]  J. Holloszy,et al.  Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling. , 2000, Journal of applied physiology.

[131]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[132]  M. Foretz,et al.  Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[133]  K. M. Popov,et al.  Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. , 1998, The Biochemical journal.

[134]  G. Heigenhauser,et al.  Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. , 2001, American journal of physiology. Endocrinology and metabolism.

[135]  S. G. Rønn,et al.  Regulation of pancreatic β-cell mass and proliferation by SOCS-3 , 2005 .

[136]  M. Birnbaum,et al.  When the usual insulin is just not enough , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[137]  Y. Terauchi,et al.  Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation , 2001, Molecular and Cellular Biology.

[138]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[139]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[140]  T. Furuyama,et al.  Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. , 2003, The Biochemical journal.

[141]  S. McKnight,et al.  Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. , 1995, Genes & development.

[142]  S. Farmer,et al.  Regulation of PPARγ activity during adipogenesis , 2005, International Journal of Obesity.

[143]  D. Accili,et al.  Regulation of insulin-like growth factor–dependent myoblast differentiation by Foxo forkhead transcription factors , 2003, The Journal of cell biology.

[144]  A. Bradley,et al.  Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.

[145]  C. Kahn,et al.  Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation , 2004, Molecular and Cellular Biology.

[146]  Z. Wu,et al.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.

[147]  A. Husch,et al.  PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. , 2008, Cell metabolism.

[148]  B. Hemmings,et al.  PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. , 2006, Journal of cell science.

[149]  H. Kaneto,et al.  Crucial Role of PDX-1 in Pancreas Development, β-Cell Differentiation, and Induction of Surrogate β-Cells , 2007 .

[150]  P. Kelly,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance , 2022 .

[151]  Robert A. Harris,et al.  Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. , 2004, Diabetes.

[152]  M. Febbraio,et al.  PGC‐1α gene expression is down‐regulated by Akt‐mediated phosphorylation and nuclear exclusion of FoxO1 in insulin‐stimulated skeletal muscle , 2005, The FASEB Journal.

[153]  B. Lamothe,et al.  Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. , 1996, The EMBO journal.

[154]  Jerry Donovan,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.

[155]  F. Hansmannel,et al.  Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. , 2006, The Biochemical journal.

[156]  Y. Kido,et al.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.

[157]  G. Barsh,et al.  Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake , 2006, Nature Medicine.

[158]  D. Cameron-Smith,et al.  Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting. , 2004, Journal of applied physiology.

[159]  Marc Montminy,et al.  TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver , 2003, Science.

[160]  F. Foufelle,et al.  SREBP transcription factors: master regulators of lipid homeostasis. , 2004, Biochimie.

[161]  Chun Li Zhang,et al.  Signaling chromatin to make muscle. , 2002, Current opinion in cell biology.

[162]  N. Sonenberg,et al.  Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice , 1996, Molecular and cellular biology.

[163]  B. Staels,et al.  Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. , 2006, The Journal of clinical investigation.

[164]  L. C. Murtaugh,et al.  Pancreas and beta-cell development: from the actual to the possible , 2006, Development.

[165]  J. Xu,et al.  Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. , 2004, The Journal of clinical investigation.

[166]  J. Kushner,et al.  Phosphatase and Tensin Homolog Regulation of Islet Growth and Glucose Homeostasis* , 2005, Journal of Biological Chemistry.

[167]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[168]  B. Lowell,et al.  Monitoring FoxO1 Localization in Chemically Identified Neurons , 2008, The Journal of Neuroscience.

[169]  Namjin Chung,et al.  Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ , 2004, Nature.

[170]  A. Goldberg,et al.  What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.

[171]  H. Kaneto,et al.  Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. , 2003, Diabetes.

[172]  Y. Chen,et al.  Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. , 1996, Genes & development.

[173]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[174]  M. Benito,et al.  Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-κB through an AKT/P70S6K/p38-MAPK pathway , 2002, Oncogene.

[175]  P. Vogt,et al.  Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[176]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[177]  Robert A. Harris,et al.  Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. , 2002, Diabetes.

[178]  Min-Seon Kim,et al.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.

[179]  J. McGarry,et al.  The glucose paradox. Is glucose a substrate for liver metabolism? , 1984, The Journal of clinical investigation.

[180]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[181]  Hendrik C Korswagen,et al.  Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.

[182]  J. Yates,et al.  A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.

[183]  Sunmin Park,et al.  Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function* , 2006, Journal of Biological Chemistry.

[184]  J. Bos,et al.  FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK , 2004, The EMBO journal.

[185]  I. Kii,et al.  Inactivation of Rho/ROCK Signaling Is Crucial for the Nuclear Accumulation of FKHR and Myoblast Fusion* , 2004, Journal of Biological Chemistry.

[186]  R. DePinho,et al.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.

[187]  H. Kaneto,et al.  Oxidative Stress Induces Nucleo-Cytoplasmic Translocation of Pancreatic Transcription Factor PDX-1 Through Activation of c-Jun NH2-terminal Kinase , 2003 .

[188]  M. Essers,et al.  Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity* , 2008, Journal of Biological Chemistry.

[189]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[190]  M. Imae,et al.  Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. , 2003, Journal of molecular endocrinology.

[191]  G. Grosveld,et al.  FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts , 2003, The EMBO journal.

[192]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[193]  E. Hietanen,et al.  Adipose, Muscle and Lung Tissue Lipoprotein Lipase Activities in Young Streptozotocin Treated Rats , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[194]  M. Birnbaum,et al.  Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator , 2007, Nature.

[195]  T. Unterman,et al.  FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. , 2005, Biochemical and biophysical research communications.

[196]  P. Puigserver,et al.  A PGC-1α-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose* , 2009, Journal of Biological Chemistry.

[197]  I. Goldberg Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.

[198]  In-kyu Lee,et al.  SREBP-1c Mediates the Insulin-dependent Hepatic Glucokinase Expression* , 2004, Journal of Biological Chemistry.

[199]  P. Butler,et al.  Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. , 2004, The Journal of clinical endocrinology and metabolism.

[200]  C. Mounier,et al.  Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins. , 2006, Endocrinology.

[201]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[202]  N. Abumrad,et al.  Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. , 2002, Annual review of nutrition.

[203]  I. Macdonald,et al.  Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans , 2006, The Journal of physiology.

[204]  P. Neufer,et al.  Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. , 2000, American journal of physiology. Endocrinology and metabolism.

[205]  E. Van Obberghen,et al.  Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. , 2007, Endocrinology.

[206]  R. Robertson,et al.  Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.

[207]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[208]  T. Unterman,et al.  The Transcription Factors HIF-1 and HNF-4 and the Coactivator p300 Are Involved in Insulin-regulated Glucokinase Gene Expression via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2004, Journal of Biological Chemistry.

[209]  D. Accili,et al.  FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.

[210]  A. Fukamizu,et al.  Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. , 2003, Diabetes.

[211]  Y. Kido,et al.  The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. , 2002, The Journal of clinical investigation.

[212]  B. Teusink,et al.  Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. , 2005, Diabetes.

[213]  S. Marklund,et al.  CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. , 1981, The Biochemical journal.

[214]  A. Bonen,et al.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.

[215]  Johannes D. Veldhuis,et al.  Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-Channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose , 2004 .

[216]  C. Newgard,et al.  Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.

[217]  K. Kaestner,et al.  Foxa2 Controls Pdx1 Gene Expression in Pancreatic β-Cells In Vivo , 2002 .

[218]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[219]  E. Greer,et al.  FOXO transcription factors at the interface between longevity and tumor suppression , 2005, Oncogene.

[220]  D. Accili,et al.  Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[221]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[222]  J. Kushner,et al.  Pdx1 restores beta cell function in Irs2 knockout mice. , 2002, The Journal of clinical investigation.

[223]  S. Bonner-Weir,et al.  Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* , 2002, The Journal of Biological Chemistry.

[224]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[225]  R. Robertson,et al.  β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .

[226]  R. Morrison,et al.  Role of PPARγ in Regulating a Cascade Expression of Cyclin-dependent Kinase Inhibitors, p18(INK4c) and p21(Waf1/Cip1), during Adipogenesis* , 1999, The Journal of Biological Chemistry.

[227]  P. Neufer,et al.  Effect of short-term fasting and refeeding on transcriptional regulation of metabolic genes in human skeletal muscle. , 2003, Diabetes.

[228]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[229]  Jeong-Ho Kim,et al.  Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. , 2008, Endocrinology.

[230]  J. Breslow,et al.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. , 1990, Science.

[231]  M. Lane,et al.  Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways* , 2003, Journal of Biological Chemistry.

[232]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[233]  H. Kaneto,et al.  The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation* , 2006, Journal of Biological Chemistry.

[234]  Dominique A. Glauser,et al.  The emerging role of FOXO transcription factors in pancreatic beta cells. , 2007, The Journal of endocrinology.

[235]  T. Kitamura,et al.  Role of FoxO Proteins in Pancreatic beta Cells. , 2007, Endocrine journal.

[236]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[237]  M. Stoffel,et al.  β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.

[238]  Hiroyuki Aburatani,et al.  Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.

[239]  K. Heidenreich,et al.  FoxO1 Regulates Multiple Metabolic Pathways in the Liver , 2006, Journal of Biological Chemistry.

[240]  Hui Chen,et al.  FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. , 2006, The Journal of biological chemistry.